Antidepressants
Lilly granted Cymbalta marketing extension
- Wed, 07/11/2012 - 11:32am
The U.S. Food and Drug Administration granted Eli Lilly & Co. six more months to market the Cymbalta.
Canada adds heart warnings to Lexapro labels
- Mon, 05/07/2012 - 4:09pm
Serotonin reuptake inhibitor Lexapro, or Cipralex, as it’s marketed in Canada, may cause heart rhythm problems. According to Health Canada, risk increases as dosage increases.
FDA approves first generic Lexapro
- Thu, 03/15/2012 - 2:06pm
- Comments
Yesterday, the Food and Drug Administration approved the first generic Lexapro (escitalopram tablets) to treat
Birth defects caused by antidepressants provoke lawsuit
- Wed, 03/14/2012 - 9:43am
- Comments
Many researchers debate whether it is safe for women to take antidepressants during pregnancy.